1. "2009"
Formats
  1. Journal Article (1884)
  2. Meeting Abstract (566)
  3. Book Section (195)
  4. Conference Paper (22)
  5. Book Whole (16)
Groups
  1. Department of Medicine (784)
  2. Surgery (698)
  3. GSK Faculty (533)
  4. Sloan Kettering Institute Faculty (480)
  5. Solid Tumor Oncology Division (413)
  6. Survivorship Research (335)

More Groups

People
  1. Dennis Chi (53)
  2. Richard Barakat (51)
  3. Peter Scardino (47)
  4. Nadeem Abu-Rustum (44)
  5. Valerie Rusch (44)
  6. Yuman Fong (41)

More People

Years
  1. 2009 (2683)
Publications
  1. Journal of Clinical Oncology (219)
  2. Cancer Research (84)
  3. Blood (82)
  4. Gynecologic Oncology (64)
  5. Cancer Rehabilitation: Principles and Practice. 1st ed (51)
  6. Journal of Thoracic Oncology (44)

More Publications

Publishers
  1. Elsevier Inc. (297)
  2. American Society of Clinical Oncology (222)
  3. Elsevier Science, Inc. (164)
  4. Lippincott Williams & Wilkins (144)
  5. American Association for Cancer Research (143)
  6. Springer (137)

More Publishers

Results (2683)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predicting the long-term risk of prostate cancer-specific mortality after radical prostatectomy
    Meeting Abstract

    Stephenson, A. J.; Klein, E. A.; Kattan, M. W.; Han, M.; Partin, A. W.; Walsh, P. C.; Trock, B. J.; Wood, D. P.; Eggener, S. E.; Eastham, J. A.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Bioluminescence evaluation of efficacy of oncolytic treatment with Newcastle disease virus (NDV) in malignant pleural mesothelioma
    Meeting Abstract

    Silberhumer, G.; Brader, P.; Wong, J.; Zamarin, D.; Serganova, I.; Blasberg, R.; Palese, P.; Fong, Y.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Adherence to extracolonic cancer screening in Lynch syndrome kindreds
    Meeting Abstract

    Stadler, Z. K.; Stern, R.; Devlin, V.; Glogowski, E.; Kauff, N.; Offit, K.; Hurley, K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Immunologic impact of anti-CTLA-4 therapy
    Meeting Abstract

    Sharma, P.; Tsavachidou, D.; Kamat, A.; Tang, D. N.; Chen, H.; Fu, T.; Troncoso, P.; Wolchok, J.; Logothetis, C. J.; Allison, J. P.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Hereditary diffuse gastric cancer (HDGC): Clinical characteristics of a prospective cohort of HDGC patients with and without CDH1 mutation and patients with sporadic GC
    Meeting Abstract

    Shah, M. A.; Pristyazhnyuk, Y.; Jhawer, M.; Coombes, S.; Harlan, M.; Randazzo, J.; Perera, R. J.; Pascarelli, K. M.; Coit, D.; Kelsen, D. P.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase I study of XL281, a selective oral RAF kinase inhibitor, in patients (Pts) with advanced solid tumors
    Meeting Abstract

    Schwartz, G. K.; Robertson, S.; Shen, A.; Wang, E.; Pace, L.; Dials, H.; Mendelson, D.; Shannon, P.; Gordon, M.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase II study of BIBW 2992, a novel irreversible dual EGFR and HER2 tyrosine kinase inhibitor (TKI), in patients with adenocarcinoma of the lung and activating EGFR mutations after failure of one line of chemotherapy (LUX-Lung 2)
    Meeting Abstract

    Shih, J.; Yang, C.; Su, W.; Hsia, T.; Tsai, C.; Chen, Y.; Chang, H.; Terlizzi, E.; Shahidi, M.; Miller, V. A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab in combination with cetuximab plus irinotecan in irinotecan-refractory colorectal cancer (CRC) patients who have progressed on a bevacizumab-containing regimen (The BOND 2.5 Study)
    Meeting Abstract

    Segal, N. H.; Reidy-Lagunes, D.; Capanu, M.; Kemeny, N.; Chung, K.; Kelsen, D.; Hollywood, E.; Goodman-Davis, N.; Saltz, L. B.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • DNA mismatch repair protein defects and endometrial cancer in women age 40 and younger
    Meeting Abstract

    Shih, K. K.; Garg, K.; Levine, D. A.; Kauff, N.; Abu-Rustum, N. R.; Soslow, R. A.; Barakat, R. R.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Antitumor activity of MDV3100 in a phase I/II study of castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Scher, H. I.; Beer, T. M.; Higano, C. S.; Taplin, M.; Efstathiou, E.; Anand, A.; Hung, D.; Hirmand, M.; Fleisher, M.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save